DBRS Morningstar Confirms Ratings on Lendmark Funding Trust 2016-B

DBRS, Inc. (DBRS Morningstar) has confirmed its ratings on the outstanding Series issued by Lendmark Funding Trust 2016-B, as outlined below. The performance of the transaction is such that credit enhancement is sufficient to cover the DBRS Morningstar loss expectations at the current rating level.

-- Series 2016-B, Class II-A Notes, at A (sf)
-- Series 2016-B, Class I-A Notes, at BBB (sf)
-- Series 2016-B, Class II-B Notes, at BBB (sf)
-- Series 2016-B, Class III-A Notes, at BBB (sf)

The transaction is a securitization of consumer loans. The deal benefits from credit enhancement consisting of overcollateralization and a reserve account. The aggregate pool balance was $45,579,457. The monthly default ratio is 0.24%.

Confirmation on the notes considers DBRS Morningstar’s set of macroeconomic scenarios for select economies related to the Coronavirus Disease (COVID-19), available in its commentary “Global Macroeconomic Scenarios: December Update,” published on December 2, 2020. DBRS Morningstar initially published macroeconomic scenarios on April 16, 2020, which have been regularly updated. The scenarios were last updated on December 2, 2020, and are reflected in DBRS Morningstar’s rating analysis.

The assumptions consider the moderate macroeconomic scenario outlined in the commentary, with the moderate scenario serving as the primary anchor for current ratings. The moderate scenario factors in increasing success in containment during the first half of 2021, enabling the continued relaxation of restrictions.

A description of how DBRS Morningstar considers ESG factors within the DBRS Morningstar analytical framework and its methodologies can be found at https://www.dbrsmorningstar.com/research/357792.

Notes:
All figures are in U.S. dollars unless otherwise noted.

The principal methodology is the DBRS Morningstar Master U.S. ABS Surveillance (May 27, 2020), which can be found on dbrsmorningstar.com under Methodologies & Criteria.

For more information regarding rating methodologies and Coronavirus Disease (COVID-19), please see the following DBRS Morningstar press release: https://www.dbrsmorningstar.com/research/357883

For more information regarding structured finance rating methodologies and Coronavirus Disease (COVID-19), please see the following DBRS Morningstar press release: https://www.dbrsmorningstar.com/research/358308.

For more information regarding the structured finance rating approach and Coronavirus Disease (COVID-19), please see the following DBRS Morningstar press release: https://www.dbrsmorningstar.com/research/359905.

The rated entity or its related entities did participate in the rating process for this rating action. DBRS Morningstar had access to the accounts and other relevant internal documents of the rated entity or its related entities in connection with this rating action.

This rating is endorsed by DBRS Ratings Limited for use in the European Union. The following additional regulatory disclosures apply to endorsed ratings:

The last rating action on this transaction took place on April 12, 2019, when DBRS Morningstar confirmed the ratings on Series 2016-B, Class II-A and Series 2016-B, Class II-B, rated A (sf) and BBB (sf), respectively. Additionally, DBRS issued the ratings on Series 2016-B, Class I-A and Series 2016-B, Class III-A rated BBB (sf) and BBB (sf), respectively.

For further information on DBRS Morningstar historical default rates published by the European Securities and Markets Authority (ESMA) in a central repository, see: http://cerep.esma.europa.eu/cerep-web/statistics/defaults.xhtml.

Lead Analyst: Chris O'Connell, Senior Vice President, U.S. ABS – Global Structured Finance
Rating Committee Chair: Chris D’Onofrio, Managing Director, Head of U.S. ABS
Global Structured Finance DBRS, Inc.
Initial Rating Date: October 26, 2016

For more information on this credit or on this industry, visit www.dbrsmorningstar.com or contact us at [email protected].

DBRS, Inc.
140 Broadway, 43rd Floor
New York, NY 10005 USA
Tel. +1 212 806-3277

DBRS Morningstar Master U.S. ABS Surveillance Methodology (May 27, 2020) https://www.dbrsmorningstar.com/research/361480/dbrs-morningstar-master-us-abs-surveillance